BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy.
Bönhof GJ, Sipola G, Strom A, Herder C, Strassburger K, Knebel B, Reule C, Wollmann JC, Icks A, Al-Hasani H, Roden M, Kuss O, Ziegler D.
BMJ Open. 2022 Feb 3;12(2):e057142. doi: 10.1136/bmjopen-2021-057142.
PMID:35115359
Diabetic Neuropathies.
Elafros MA, Callaghan BC.
Continuum (Minneap Minn). 2023 Oct 1;29(5):1401-1417. doi: 10.1212/CON.0000000000001291.
PMID:37851036
Diabetic Polyneuropathy Early in Type 2 Diabetes Is Associated With Higher Incidence Rate of Cardiovascular Disease: Results From Two Danish Cohort Studies.
Bjerg L, Nicolaisen SK, Christensen DH, Nielsen JS, Andersen ST, Jørgensen ME, Jensen TS, Sandbæk A, Andersen H, Beck-Nielsen H, Sørensen HT, Witte DR, Thomsen RW, Charles M.
Diabetes Care. 2021 Jul;44(7):1714-1721. doi: 10.2337/dc21-0010. Epub 2021 May 26.
PMID:34039686
Pain in Patients With Type 2 Diabetes-Related Polyneuropathy Is Associated With Vascular Events and Mortality.
Lapin BR, Pantalone KM, Milinovich A, Morrison S, Schuster A, Boulos F, Johnson K, Thakore NJ.